Skip to main content
. 2016 Apr 20;7(22):33081–33095. doi: 10.18632/oncotarget.8859

Table 3. Top differentially regulated genes between mammary tumors and DTC tumorsa.

Gene Symbol log2 Fold Change mammary vs. DTC tumor P Value
Tfap2b 4.00 0.00004
Abpb 2.66 0.02277
Mfi2 1.72 0.01500
Arhgef6 1.62 0.03335
Igfals 1.54 0.01500
S100b 1.27 0.03968
Crabp2 1.27 0.02177
Nes 1.26 0.01500
Cpeb2 1.18 0.04957
C630004H02Rik 1.07 0.02490
Cgrrf1 1.06 0.03335
Clybl 1.04 0.04957
Slc44a3 1.02 0.03936
Vegfa −1.03 0.04872
Itga9 −1.21 0.03968
Il2rg −1.24 0.02322
Ppp1r9a −1.36 0.01500
Pfkfb3 −1.42 0.01808
Bnip3 −1.87 0.03936
Eps8 −1.95 0.01808
Adm −2.00 0.01808
Ndrg1 −2.28 0.01500
Tspan8 −2.30 0.04836
2610528A11Rik −2.51 0.04746
Dcpp1 −3.93 0.01500
Dcpp2 −4.59 0.02490
a)

RNA from DTC tumors and mammary tumors where used to hybridize Affymetrix chips. Top differentially expressed genes were calculated using cut-off of 0.05 P value with the Bonferroni correction method. The table lists differentially expressed genes (gene symbols), their magnitude expressed as fold change of mammary vs. DTC tumor expression level (Log2 Fold Change) and the False Discovery Rate (FDR) P-value score.